Antimicrobial susceptibility of Riemerella anatipestifer strains isolated from geese and ducks in Hungary by Gyuris, Éva et al.
Acta Veterinaria Hungarica 65 (2), pp. 153–165 (2017) 
DOI: 10.1556/004.2017.016 
 
0236-6290/$ 20.00 © 2017 Akadémiai Kiadó, Budapest 
ANTIMICROBIAL SUSCEPTIBILITY OF RIEMERELLA 
ANATIPESTIFER STRAINS ISOLATED FROM GEESE  
AND DUCKS IN HUNGARY 
Éva GYURIS1, Enikő WEHMANN2, Katalin CZEIBERT1 and Tibor MAGYAR2* 
1Laboratory of Domestic Mammal, Wildlife and Poultry Diseases, National Food Chain 
Safety Office – Veterinary Diagnostic Directorate, Budapest, Hungary; 2Institute for  
Veterinary Medical Research, Centre for Agricultural Research, Hungarian Academy of 
Sciences, P.O. Box 18, H-1581 Budapest, Hungary 
(Received 14 November 2016; accepted 4 April 2017) 
Riemerella anatipestifer causes anatipestifer disease in many avian species. 
A total of 185 R. anatipestifer strains isolated in Hungary between 2000 and 2014 
from geese and ducks were tested against 13 antibiotics (ampicillin, doxycycline, 
enrofloxacin, erythromycin, florfenicol, flumequine, gentamicin, penicillin, spectin-
omycin, streptomycin, sulphamethoxazole–trimethoprim, sulphonamide compounds, 
and tetracycline) by the Kirby-Bauer disk diffusion method. The majority of the 
strains were susceptible to florfenicol (97.9%), ampicillin (95.1%), penicillin (93%), 
sulphamethoxazole–trimethoprim (92.4%), and spectinomycin (86.5%). The highest 
resistance rates were observed for flumequine, tetracycline, erythromycin and 
streptomycin (94%, 91.4%, 75.1% and 71.4% resistance, respectively). The resis-
tance patterns showed some variation depending on the geographical origin of the 
strains. The average rate of extensive drug resistance was 30.3%, and its propor-
tion tended to increase in the period examined. 
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Anatipestifer disease caused by Riemerella anatipestifer infection is 
prevalent in all countries where intensive goose and duck production is practised. 
It causes significant economic losses through high mortality, reduced growth rate 
and the costs of treatment and prevention (Ruiz and Sandhu, 2013). Since its first 
description in geese by Riemer (1904), the disease has been reported regularly, 
but the taxonomic position of the aetiological agent remained uncertain for many 
years (Hendrickson and Hilbert, 1932; Bruner and Fabricant, 1954; Breed et al., 
1957). Finally Segers et al. (1993) named the agent R. anatipestifer and sug-
gested its transfer to a separate genus (Riemerella) based on phenotypic and 
genotypic characteristics.  
Riemerella anatipestifer causes anatipestifer disease primarily in young, 2- 
to 8-week-old goslings and ducklings; however, severe losses have been reported 
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in turkey flocks as well (Helfer and Helmboldt, 1977; Smith et al., 1987; From-
mer et al., 1990). The disease has also been described in chickens, pheasants, 
guinea fowl, quails, gulls, budgerigars, and wild waterfowl (Bruner et al., 1970; 
Karstad et al., 1970; Rosenfeld, 1973; Pascucci et al., 1989; Hinz et al., 1998). 
The clinical signs of anatipestifer disease include nasal discharge, cough-
ing, sinusitis, diarrhoea and neural signs such as torticollis, head tremor and 
lameness (Bisgaard et al., 2008; Fulton and Rimler, 2010). The gross lesions are 
similar in different avian species and include a slightly enlarged spleen, fibrinous 
pericarditis, perihepatitis, airsacculitis, catarrhal rhinitis, pneumonia, purulent ar-
thritis, catarrhal enteritis, as well as caseous exudate in the oviducts, skin necro-
sis and serous-fibrinous meningitis (Dougherty et al., 1955; Smith et al., 1987; 
Bisgaard et al., 2008). The disease may persist for two weeks without appropriate 
treatment, and mortality may vary from 10% to 75% (Ruiz and Sandhu, 2013). 
In Hungary, anatipestifer disease was first described by Bitay et al. (1979) 
in ducks, while Ivanics et al. (1996) reported its first occurrence in geese. 
Twenty-one serotypes of R. anatipestifer are known to date, and no cross-
protection has been observed between the different serotypes. In addition, more 
than one serotype can be present in the same farm (Ruiz and Sandhu, 2013). These 
facts underline the importance of antibiotics in controlling anatipestifer disease. 
The aim of this study was to determine the antibiotic susceptibility pat-
terns of 185 R. anatipestifer strains against 13 antibiotics. 
 
 
Materials and methods 
Bacterial strains 
A total of 185 R. anatipestifer strains were isolated from 2000 to 2014 
from 100 flocks of geese or ducks located at 48 settlements of six counties in 
Hungary (Fig. 1). 
All strains were recovered from 5- to 140-day-old birds that had died of 
anatipestifer disease. Samples taken from the liver, brain, pericardium or lung 
were cultured on Columbia agar plates (Biolab, Budapest, Hungary) supple-
mented with 5% defibrinated sheep blood at 37 °C for 24 h in an atmosphere 
containing 5% CO2. A total of 158 strains originated from geese and 27 strains 
from ducks. The strains were identified by colony morphology, Gram staining 
and a species-specific polymerase chain reaction (PCR) (Kardos et al., 2007). All 
isolates were stored at –70 °C until analysed. Table 1 shows the properties of the 
R. anatipestifer strains used in this study. 
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Fig. 1. Geographic origin of the Riemerella anatipestifer strains used in this study 
Susceptibility testing 
Antibiotic susceptibility was assessed by the Kirby–Bauer disk diffusion 
method. The isolates were tested for susceptibility to 13 antibiotics: ampicillin 
(10 µg) [equivalent to the recently used amoxicillin (10 µg)], doxycycline (30 µg), 
enrofloxacin (5 µg), erythromycin (15 µg), florfenicol (30 µg), flumequine (30 µg), 
gentamicin (10 µg), penicillin (10 IU), spectinomycin (100 µg), streptomycin 
(10 µg), sulphamethoxazole–trimethoprim (23.75 + 1.25 µg), sulphonamide com-
pounds (300 µg), and tetracycline (30 µg) (Biolab, Budapest, Hungary). 
The tests were carried out according to the guidelines of the Clinical and 
Laboratory Standards Institute (CLSI, 2013, 2015). Strains were grown on Co-
lumbia agar plates supplemented with 5% defibrinated sheep blood at 37 °C in 
5% CO2 atmosphere. Colonies were suspended in 0.85% saline, and the turbidity 
was adjusted to 0.5 McFarland standard. The disk diffusion analysis was per-
formed on Mueller–Hinton agar (Biolab, Budapest, Hungary) enriched with 5% 
sheep blood. Inhibitory zone diameters were measured after 24 h of incubation. 
The resistance breakpoints (Table 2) were interpreted according to the criteria 
provided by CLSI documents M100-S21 and VET01S (CLSI, 2013, 2015) and 
the National Food Chain Safety Office, Veterinary Diagnostic Directorate (Bu-
dapest, Hungary). 
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Table 1 
Properties of the Riemerella anatipestifer strains used in this study 
Geographic origin (county) Host Year of isolation Number 
goose 2000 8 
 2006 11 
 2010 24 
 2011 12 
 2012 28 
 2013 21 
 2014 24 
duck 2006 3 
 2010 1 
 2011 7 
 2012 2 
 2013 6 
Bács-Kiskun 
 2014 3 
goose 2014 2 
Békés 
duck – – 
goose 2010 3 
 2011 4 
 2012 2 
 2013 1 
 2014 2 
duck 2013 1 
Csongrád 
 2014 2 
goose 2009 1 
 2010 1 
 2011 1 Hajdú-Bihar 
duck 2014 1 
goose 2004 1 
 2010 1 
 2013 5 Jász-Nagykun-Szolnok 
duck 2013 1 
goose 2012 1 
 2013 1 
 2014 4 Pest 
duck – – 
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Table 2 
Resistance breakpoints of the antibiotics used in this study 
Zone diameter (mm) 
Interpretive criteria Antibiotic 
Susceptible Intermediate Resistant 
Penicillin ≥ 24 – ≤ 23 
Ampicillin ≥ 24 – ≤ 23 
Gentamicin ≥ 15 13–14 ≤ 12 
Streptomycin ≥ 15 12–14 ≤ 11 
Spectinomycin ≥ 17 16 ≤ 15 
Enrofloxacin ≥ 23 17–22 ≤ 16 
Flumequine ≥ 24 20–23 ≤ 19 
Tetracycline ≥ 23 – ≤ 22 
Doxycycline ≥ 23 – ≤ 22 
Erythromycin ≥ 23 14–22 ≤ 13 
Sulphonamide compounds ≥ 17 13–16 ≤ 12 
Sulphamethoxazole–trimethoprim ≥ 16 11–15 ≤ 10 
Florfenicol ≥ 19 15–18 ≤ 14 
 
 
Results 
The majority of the strains were susceptible to florfenicol (97.9%), am-
picillin (95.1%), penicillin (93%), sulphamethoxazole–trimethoprim (92.4%) and 
spectinomycin (86.5%). Enrofloxacin and sulphonamide compounds proved to be 
less effective (26% and 27% resistance, respectively), although the rate of inter-
mediate susceptibility was unusually high for enrofloxacin (60%). Approximately 
50% of the strains were resistant to gentamicin and doxycycline. The highest re-
sistance rates were observed for flumequine, tetracycline, erythromycin and 
streptomycin (94%, 91.4%, 75.1% and 71.4% resistance, respectively) (Fig. 2). 
Changes in the antibiotic resistance profiles of the strains over time were 
also evaluated (Table 3). A tendency of increase was noted in the rate of resis-
tance to erythromycin, florfenicol, spectinomycin and streptomycin from 2000, 
sulphonamide compounds from 2004, and doxycycline from 2009. The rate of 
resistance to other antibiotics showed a variable tendency. 
We examined the resistance pattern of four strains isolated within three 
weeks from one outbreak in a farm (Table 4). The strains displayed an expanding 
resistance pattern, showing resistance to 4, 4, 5 and finally 7 antibiotics out of the 
13 antibiotics examined. 
Strains isolated from the north-western part of Bács-Kiskun County 
showed the highest resistance rate to doxycycline, gentamicin, spectinomycin, 
sulphamethoxazole–trimethoprim, sulphonamide compounds and tetracycline. 
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Strains collected from the south-western part of Bács-Kiskun County possessed 
the lowest resistance rate to flumequine, gentamicin, spectinomycin and strepto-
mycin (Table 5). 
 
Fig. 2. Antimicrobial susceptibility of 185 Riemerella anatipestifer strains tested against 13 differ-
ent antibiotics 
 
Strains non-susceptible to at least one agent in all but two or fewer anti-
microbial categories were defined as extensively drug-resistant (XDR) strains. 
Non-susceptibility refers to either a resistant, intermediate or non-susceptible re-
sult obtained from in vitro antimicrobial susceptibility testing (Magiorakos et al., 
2012). The average rate of extensive drug resistance was 30.3% for all isolates. 
No XDR strain was found in 2000. Isolates collected between 2004 and 2006 
showed 6.6% extensive drug resistance. The proportion of extensive drug resis-
tance was 38.7% for strains isolated from 2009 to 2010. Isolates collected from 
2011, 2012, 2013 and 2014 showed an increasing tendency of extensive drug re-
sistance: 20.8%, 18%, 30.5% and 55.3%, respectively. 
The rate of extensive drug resistance showed some variance according to 
the geographical origin of the strains. The proportion of extensive drug resistance 
was above average for strains isolated from the north-western part of Bács-
Kiskun County and Csongrád County: 36.3% and 40%, respectively. Isolates 
collected from the north-eastern and south-western part of Bács-Kiskun County 
showed 31.4% and 31.2% extensive drug resistance, respectively. The proportion 
of extensive drug resistance among strains isolated from the south-eastern part of 
Bács-Kiskun County was below average (28.3%). 
The proportion of XDR strains isolated from geese and ducks was 31% 
and 26%, respectively. The rate of resistance to different antibiotics was irrespec-
tive of the host species. 
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Discussion 
Due to the lack of a vaccine showing cross-protection among different se-
rotypes of R. anatipestifer, the frequent change of serotypes in farms and the 
common presence of more than one serotype in a farm, antibiotics are still im-
portant tools for controlling anatipestifer disease. On the other hand, the threat of 
emergence of antibiotic resistance makes it extremely important to monitor bac-
terial pathogens for antibiotic susceptibility. 
Riemerella anatipestifer strains in this study were generally sensitive to 
penicillin, with only 7% of the strains proving to be resistant. Earlier studies re-
ported similar findings in Thailand and Taiwan (Pathanasophon et al., 1994; 
Chang et al., 2003); however, about five years later 58% of the strains showed 
resistance to penicillin in Taiwan (Yu et al., 2008). During the same period, Chi-
nese authors also observed a high (86.9%) resistance rate to penicillin (Zhong et 
al., 2009). Ampicillin was also found effective in this study. Interestingly, iso-
lates in China showed remarkable changes in resistance to this antibiotic over 
time: 58.4% of the strains were resistant in 2009, all strains were sensitive in 
2012, and 93% of the strains were resistant in 2015 (Zhong et al., 2009; Sun et 
al., 2012; Zheng et al., 2015). 
Among aminoglycosides and aminocyclitols, spectinomycin was the most 
effective agent (only 7% resistance), while gentamicin and streptomycin showed 
higher resistance rates (56.8% and 71.4%, respectively). Aminoglycosides and 
aminocyclitols are poorly, or not at all, absorbed from the gut, and thus the oral 
administration of these antibiotics is not recommended in cases of bacterial sep-
ticaemia (Gálfi et al., 2012). Chinese authors observed a similar tendency of re-
sistance to spectinomycin (11.3%), gentamicin (20.8%), and streptomycin (42.5%) 
(Zhong et al., 2009). At the same time, strains isolated in Taiwan proved to be 
highly resistant to all these aminoglycosides and aminocyclitols (Chang et al., 
2003). German authors also observed over 90% resistance to gentamicin (Köhler 
et al., 1995). These findings indicate that there is a variable degree of cross-
resistance among aminoglycosides, presumably because of the existence of di-
verse bacterial enzymes that can inactivate these antibiotics. 
Twenty-six percent of our R. anatipestifer strains were resistant to enro-
floxacin (a Class 2 second-generation fluoroquinolone), while a surprisingly high 
percent of the isolates (60%) showed intermediate susceptibility to this agent. 
Flumequine (a Class 1 second-generation fluoroquinolone) proved to be less ef-
fective (94% resistance). Authors in Taiwan made a similar observation: 83% of 
the local strains were susceptible to enrofloxacin, while 81% of them were resis-
tant to flumequine (Yu et al., 2008). In our study, all but 22 out of the 174 flume-
quine-resistant strains showed decreased sensitivity to enrofloxacin (there were 
47 resistant and 105 intermediately susceptible strains). These data support the 
observation that a fluoroquinolone of advanced generation such as enrofloxacin 
162 GYURIS et al. 
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could break through the resistance to flumequine, although its sensitivity often 
decreases after a while (Gálfi et al., 2012). 
The rate of resistance to tetracycline was high (91.4%) among the Hungar-
ian strains, while resistance to doxycycline occurred in a lower percentage (59%). 
Strains from Taiwan showed a similar trend: 69% of the isolates were resistant to 
tetracycline, whereas only 35% of the strains proved to be resistant to doxycy-
cline (Yu et al., 2008). Chinese R. anatipestifer strains were more sensitive: the 
ratio of resistance was 46.6% to tetracycline and 24.4% to doxycycline (Zhong et 
al., 2009). This tendency is consistent with the fact that cross-resistance exists 
among tetracyclines, although some members of this group (like doxycycline or 
minocycline) can break through this resistance. 
Up to 75.1% of our strains were resistant to erythromycin. The resistance 
rate in other countries varied: Chinese authors found 32.7% resistance (Zhong et 
al., 2009), while authors from Taiwan observed 64% resistance (Yu et al., 2008). 
We found only 1.6% resistance to florfenicol, in accordance with data re-
ported from China (Sun et al., 2012). 
Twenty-seven percent of our strains were resistant to sulphonamide com-
pounds, while only 4.3% showed resistance to sulphamethoxazole–trimethoprim. 
Sun et al. (2012) found that Chinese isolates were resistant to sulphonamide, while 
two thirds of the strains were susceptible to sulphamethoxazole–trimethoprim. 
These data suggest that the sulphamethoxazole–trimethoprim combination is still 
effective. 
We have also evaluated the changes of antibiotic resistance profiles over time. 
The rates of resistance to erythromycin, spectinomycin, streptomycin (2000–2014) 
and sulphonamide compounds (2004–2014) tended to increase. The rate of resis-
tance to other antibiotics showed variable trends. Our results are in accordance 
with the results of Zhong et al. (2009), who found that the rates of resistance to 
piperacillin and cefoperazone increased and those to spectinomycin and aztreo-
nam decreased from 1998 to 2005 in China, while no regular patterns were ob-
served for other antibiotics. The authors speculated that the improper use of anti-
biotics might lead to higher antibiotic resistance rates. Other authors reported 
similar results, observing a high resistance rate of R. anatipestifer isolates from 
ducks, and explaining it by the overuse and improper application of antibiotics in 
duck farms (Sun et al., 2012). On the other hand, an increase in susceptibility 
may occur to antibiotics that had not been used for a while (Zhong et al., 2009). 
The average rate of extensive drug resistance was 30.3%. The proportion 
of extensive drug resistance also tended to increase over time. For strains isolated 
in 2000, 2004–2006, 2009–2010, 2011, 2012, 2013 and 2014, the rate of exten-
sive drug resistance was 0%, 6.6%, 38.7%, 20.8%, 18%, 30.5% and 55.3%, re-
spectively. These results are in harmony with the findings of Köhler et al. (1995), 
who observed an increasing proportion of multidrug-resistant isolates over time. 
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The results obtained for our strains isolated from an outbreak within a 
three-week period support the assumption that local antibiotic usage may facili-
tate the emergence of antimicrobial resistance. These strains showed resistance 
against an increasing number of antibiotics (4 to 7). The history did not provide 
information about the antibiotics used for therapy; however, resistance emerged 
to antibiotics commonly used in poultry practice, such as doxycycline, enroflox-
acin, gentamicin, and spectinomycin. Although this observation is based on only 
a few samples, it calls attention to a possible unfavourable side effect of antibi-
otic usage, the rapid spread of antibiotic resistance. This view is supported by 
Zhong et al. (2009), who described remarkable differences in resistance patterns 
that largely depended on antibiotic usage on various farms. 
Chang et al. (2003) compared the micro-inhibitory concentrations of 
kanamycin against strains isolated in Taiwan and in the USA. They found sig-
nificant differences between the two countries, most likely due to variations in 
their antibiotic usage. In our study, in conformity with data of the literature, re-
sistance patterns and the proportion of XDR strains showed some correlation 
with their geographic origin. Again, the most probable reason is the dissimilarity 
in therapeutic practices. 
The World Health Organization has ranked antibiotics according to their 
relevance in human medicine. The criteria for critically important antibiotics are 
(1) frequent use in human medicine; (2) an antibiotic that is the only one or one 
of a few alternative medicines; and (3) evidence of transmission of bacteria or 
genes to humans from non-human sources. Some agents from these antimicrobial 
classes belong to critically important antibiotics: aminoglycosides, ansamycins, 
carbapenems, third and fourth generation cephalosporins, glycopeptides, lipopep-
tides, macrolides, oxazolidinones, penicillins, quinolones, streptogramins, tetra-
cyclines, and drugs used against mycobacterial diseases. Taking this into consid-
eration when choosing antibiotics for the treatment of food-producing animals 
may help to maintain the effectiveness of antibiotics relevant in human medicine 
(Collignon et al., 2009). 
The development of antibiotic resistance of pathogenic bacteria and the 
emergence of multidrug-resistant strains represent a growing threat to animal and 
human health. The overuse and abuse of antibiotics presumably lead to the selec-
tion of resistant bacteria. Our findings as well as data of the literature indicate 
that the resistance rate of bacterial strains has increased over the last decades. 
This underlines the significance of reducing the use of antibiotics and the impor-
tance of the prudent and correct application of appropriate antibiotics, based on 
accurate diagnosis and antimicrobial susceptibility testing. 
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